Clinical Trial Update: Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating olanzapine for chronic nausea and/or vomiting in patients with advanced cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic and Lymphoid Cell Neoplasm
• Malignant Solid Neoplasm

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Mayo Clinic | Conditions: Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm | Phase 3 | Status: WITHDRAWN